BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1341882)

  • 1. Mucin-positive epithelial mesothelioma.
    MacDougall DB; Wang SE; Zidar BL
    Arch Pathol Lab Med; 1992 Aug; 116(8):874-80. PubMed ID: 1341882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
    Leong AS; Stevens MW; Mukherjee TM
    Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
    Friedman HD; Litovsky SH; Abraham JL
    Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.
    McCaughey WT; Colby TV; Battifora H; Churg A; Corson JM; Greenberg SD; Grimes MM; Hammar S; Roggli VL; Unni KK
    Mod Pathol; 1991 May; 4(3):342-53. PubMed ID: 2068061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma.
    Hammar SP
    Ultrastruct Pathol; 2006; 30(1):3-17. PubMed ID: 16517466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelioma as a risk indicator of asbestos exposure: the role of the pathologist.
    Zampi G; Comin CE; Dini S
    Med Lav; 1995; 86(5):389-92. PubMed ID: 8684289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
    Warhol MJ; Hickey WF; Corson JM
    Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for human diffuse malignant mesothelioma.
    Suzuki Y
    Acta Pathol Jpn; 1992 Nov; 42(11):767-86. PubMed ID: 1281957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
    Dewar A; Valente M; Ring NP; Corrin B
    J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
    Sussman J; Rosai J
    Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
    Soini Y; Kinnula V; Kahlos K; Pääkkö P
    J Clin Pathol; 2006 Mar; 59(3):250-4. PubMed ID: 16505274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mesothelioma in infancy.
    Lin-Chu M; Lee YJ; Ho MY
    Arch Pathol Lab Med; 1989 Apr; 113(4):409-11. PubMed ID: 2650654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant mesothelioma of the pleura--diagnostic difficulties].
    Drozdowska A; Damps-Konstańska I; Kobierska-Gulida G; Madrzak J; Kuziemski K; Pieńkowska J; Ucińska R; Słomiński JM
    Pol Merkur Lekarski; 2004 Oct; 17(100):380-1. PubMed ID: 15690708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytodiagnosis of malignant mesothelioma on bronchial washing fluid, with immunocytochemical confirmation.
    Bresaola E; Pelosi G
    Acta Cytol; 1997; 41(5):1640-2. PubMed ID: 9305403
    [No Abstract]   [Full Text] [Related]  

  • 18. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histologic aspects of pleural mesothelioma].
    Mzabi Regaya S; Makni MK; Chadli A
    Arch Inst Pasteur Tunis; 1987 Oct; 64(4):399-409. PubMed ID: 3327479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Localized pleural mesotheliomas. Clinicopathological considerations on a case report].
    Barillari P; Muttillo IA; Cioè I; Caronna R; Ricci M; Sammartino P
    Minerva Chir; 1992 Oct; 47(20):1665-70. PubMed ID: 1480298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.